INCY:NASDAQ
Incyte Corp
$122.19
arrow_upward
+0.59%(+0.72) 1D
$122.31
arrow_upward
+0.10% (+0.12)bedtimeAfter hours
Closed: Sep 14, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$122.48
High
$123.34
Low
$121.28
Mkt. cap
24.77B
Avg. vol.
1.35M
Volume
0.00
P/E ratio
15.57
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
Open
$122.48
High
$123.34
Low
$121.28
Mkt. cap
24.77B
Avg. vol.
1.35M
Volume
0.00
P/E ratio
15.57
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
Zacks
·
12 hours ago
INCY Stock Gains 23% Year to Date: Buy, Sell or Hold?
Yahoo Finance
·
12 hours ago
INCY Stock Gains 23% Year to Date: Buy, Sell or Hold?
Yahoo Finance
·
18 hours ago
Incyte (INCY): 3 Reasons We Love This Stock
ad-hoc-news.de
·
21 hours ago
Incyte stock holds firm as quarterly revenue jumps 37.7 percent
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com